» Articles » PMID: 30349492

Does Cognitive Dysfunction in Bipolar Disorder Qualify As a Diagnostic Intermediate Phenotype?-A Perspective Paper

Overview
Specialty Psychiatry
Date 2018 Oct 24
PMID 30349492
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The present perspective paper addresses and discusses whether cognitive dysfunction in bipolar disorder qualifies as a diagnostic intermediate phenotype using the Robin and Guze criteria of diagnostic validity. The paper reviews current data within (1) delineation of the clinical intermediate phenotype, (2) associations of the intermediate phenotype with para-clinical data such as brain imaging and blood-based data, (3) associations to family history / genetics, (4) characteristics during long-term follow-up, and (5) treatment effects on cognition. In this way, the paper identifies knowledge gaps and suggests recommendations for future research within each of the five areas. Based on the current state of knowledge, we conclude that cognitive dysfunction does not qualify as a diagnostic intermediate phenotype or endophenotype for bipolar disorder, although promising new evidence points to emotion and reward processing abnormalities as possible putative endophenotypes.

Citing Articles

Unstructured Group Support Enhances Compliance to Pharmacological Treatment by Improving Social Cognition in Patients with Bipolar Disorder: A Pilot fMRI Study.

Wang Y, Zhang Y, Tian H, Chen M, Chen G, Jiang D Psychiatry Clin Psychopharmacol. 2024; 31(3):269-279.

PMID: 38765946 PMC: 11079713. DOI: 10.5152/pcp.2021.20019.


Association between childhood trauma, cognition, and psychosocial function in a large sample of partially or fully remitted patients with bipolar disorder and healthy participants.

Miskowiak K, Hansen K, Mariegaard J, Kessing L Int J Bipolar Disord. 2023; 11(1):31.

PMID: 37728780 PMC: 10511386. DOI: 10.1186/s40345-023-00311-w.


Social cognition and bipolar disorder: pending questions and unexplored topics.

de Siqueira Rotenberg L, Khafif T, Miskowiak K, Lafer B Braz J Psychiatry. 2023; 44(6):655-663.

PMID: 36709449 PMC: 9851752. DOI: 10.47626/1516-4446-2021-2272.

References
1.
Beats B, Sahakian B, Levy R . Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med. 1996; 26(3):591-603. DOI: 10.1017/s0033291700035662. View

2.
Alda M, McKinnon M, Blagdon R, Garnham J, MacLellan S, ODonovan C . Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. Br J Psychiatry. 2016; 210(1):54-60. DOI: 10.1192/bjp.bp.115.173930. View

3.
da Silva J, Goncalves-Pereira M, Xavier M, Mukaetova-Ladinska E . Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry. 2013; 202(3):177-86. DOI: 10.1192/bjp.bp.111.101931. View

4.
Kessing L . Depression and the risk for dementia. Curr Opin Psychiatry. 2012; 25(6):457-61. DOI: 10.1097/YCO.0b013e328356c368. View

5.
Mora E, Portella M, Forcada I, Vieta E, Mur M . Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study. Psychol Med. 2012; 43(6):1187-96. DOI: 10.1017/S0033291712001948. View